Filters applied:
Did You Mean? ?
one result


  • Book
    Sven Stegemann, editor.
    Digital : Springer2016
    Healthcare provision in an aging society: US perspective -- Healthcare provision in an aging society: European perspective -- Healthcare provision in an aging society: Japanese perspective -- Old, Very Old, and Frail -- Age and the process of aging -- Comprehensive Geriatric Assessment -- Patients' clinical characteristics, disease, experience, and perception -- Ethical considerations in performing clinical trials in and for older people -- Patient reported outcomes from a clinical to a therapeutic tool -- Pharmacokinetic and Pharmacodynamic Considerations in the Elderly Population -- The Expectation of a Treatment Model: A framework for adherence and Effectiveness -- Pharmacoepidemiology and pharmacovigilance for safety and efficacy in older people -- Defining patient centric drug product design and its impact on improving safety and effectiveness -- Dosing considerations in older adults -- Oral Drug Product Use in the Elderly Patient Population -- Drug product development for older adults -- multiparticulate formulations -- Considerations for topical and transdermal drug delivery in older adults -- Injectable drug delivery for older patients -- Inhalation and Nasal Formulations -- Ophthalmic drug development and the elderly -- Developing drug administration devices for use by older patients -- Manufacturing Platforms for Patient-Centric Drug Products -- Novel Manufacturing Technologies for the Production of Patient-Centric Drug Products -- Prescribing to Older Adults -- Multimorbidity and Polypharmacy -- Vaccination in Older Adults -- Medication Reviews in Older Adults -- The Personalization of Drug therapy for Elderly patients -- Importance of Clinical Nutrition in Therapy to Older Adults -- Managing drug therapy of older patients in primary and secondary care -- Medication adherence and monitoring -- Medication compounding in the provision of drug therapy -- Geriatric Pharmacotherapy: Optimisation through integrated approach in the hospital setting -- European Medicines Agency (EMA): Regulatory perspectives on geriatric medicines -- Views on the Therapeutic Needs of Older Adults -- Future Perspectives in drug therapy of older people -- Opportunities in drug product development in an aging population.